NasdaqGS:GILDBiotechs
Gilead Sciences (NasdaqGS:GILD) Partners With Global Fund To Supply HIV Prevention Drug
Gilead Sciences (NasdaqGS:GILD) recently announced a partnership with the Global Fund to supply lenacapavir for HIV prevention, marking a significant client collaboration. This and other positive events, such as the FDA's approval of Yeztugo for PrEP and clinical trial successes, highlight the company's active engagement in expanding access and treatment options. These factors may have bolstered investor confidence, aligning with a broader market trend, which saw modest gains amid trade...